Tender Details
Ref No 20227723
Document

Tender Notice

Bidding

Not specified

Short Description

25_Aife_Tma_Si_Commande_Publique
Deadline *
Date 09 Oct 2025
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location France
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 3695292
  • Location: United States

Services For Dhs Clients Under The Limited Supports Waiver

  • Deadline: 01 Dec 2025
  • Ref No: 5310892
  • Location: Germany

Drug Contracts With An Option To Join

  • Deadline: 01 May 2026
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026
  • Ref No: 4640403
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640423
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640900
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640967
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4641684
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4641976
  • Location: Germany

Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55

  • Deadline: 28 Feb 2026
  • Ref No: 4643255
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4643536
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4656274
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
WhatsApp Chat